Table 2.
ENDA proposal | American proposal | |||
---|---|---|---|---|
SPT (mg/mL) | IDT (mg/mL) | SPT (mg/mL) | IDT (mg/mL) | |
Thiopental | 25 | 2.5 | 0.2 | |
Propofol | 10 | 1 | 10–1 | 10–0.1 |
Ketamine | 10 | 1 | 10 | 0.25 |
Etomidate | 2 | 0.2 | 2 | 0.2–0.002 |
Midazolam | 5 | 0.5 | 5 | 0.5–0.25 |
Fentanyl | 0.05 | 0.005 | 0.05 | 0.005–0.000005 |
Alfentanil | 0.5 | 0.05 | ||
Sufentanil | 0.005 | 0.0005 | ||
Remifentanil | 0.05 | 0.005 | ||
Morphine | 1 | 0.01 | ||
Atracurium | 1 | 0.01 | 10 | 0.01 |
Cis-atracurium | 2 | 0.02 | 2 | 0.01–0.001 |
Mivacurium | 0.2 | 0.002 | ||
Rocuronium | 10 | 0.05 | 10 | 0.01–0.001 |
Vecuronium | 4 | 0.4 | 10 | 0.1–0.001 |
Pancuronium | 2 | 0.2 | 2 | 0.02 |
Suxamethonium | 10 | 0.1 | ||
Chlorhexidine | 5 | 0.002 | 1.2 | 0.00048 |
Alcuronium | 0.005 | |||
Methohexital | 0.1 | |||
Metocurine | 0.002 | |||
Succinylcholine | 20 | 0.02–0.05 | ||
Thioamyl | 0.1 | |||
Tubocuranine | 0.0003–0.0001 |
ENDA European Network for Drug Allergy, SPTs skin prick tests, IDTs Intradermal tests